Phase 4 Study of Clopidogrel in Patients With Stable Coronary Artery Disease to Determine Effects on Vascular Function, Biomarkers and Endothelial Progrenitor Cells
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Clopidogrel (Primary)
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Biomarker; Pharmacodynamics
- Acronyms APECS
Most Recent Events
- 01 May 2015 Biomarkers information updated
- 02 Feb 2011 New trial record